The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for MacoPharma sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
MacoPharma SA (MacoPharma) is a medical device company that develops, manufactures, and sells infusion, transfusion and biotherapy systems. The company provides transfusion products for blood collection, blood processing and blood safety and infusion systems for the easy infusion administration. Its biotherapy products include cord blood, bio banking, cell culture, photopheresis and transplant products that are used in the areas of regenerative medicine, cell and tissue therapy and transplantation. MacoPharma also offers surgical and pediatric masks. The company offers its products through a distribution network in France, Austria, Belgium, Croatia, Australia, Chile, China, Bangladesh, Finland, Hong Kong, Indonesia, and Italy, and among others. MacoPharma is headquartered in Tourcoing, France. Key subsidiaries of MacoPharma include MacoSpania, Macopharma USA, MacoPharma Benelux, MacoPharma Nederland and MacoPharma Italia.
The key metrics of MacoPharma related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As MacoPharma is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as MacoPharma.
For a detailed understanding of the performance of MacoPharma, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
